TianYu Bio-Technology Co., Ltd. (SHA:603717)
China flag China · Delayed Price · Currency is CNY
5.33
+0.15 (2.90%)
Nov 11, 2026, 3:00 PM CST

TianYu Bio-Technology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-194.13-106.9-107.36-461.64-279.41-214.74
Depreciation & Amortization
59.3759.3764.4564.6543.718.12
Other Amortization
1.721.721.250.990.730.9
Loss (Gain) From Sale of Assets
-25.97-25.970.67-0.99-47.44-8.81
Asset Writedown & Restructuring Costs
2.412.417.9314.9758.571.8
Loss (Gain) From Sale of Investments
-4.52-4.520.21109.7-1.84-17.47
Provision & Write-off of Bad Debts
-3.83-3.8320.412.2247.64170.58
Other Operating Activities
86.4987.1676.8417.493.7846.9
Change in Accounts Receivable
60.7360.73-56.5629.49-290.33-84.1
Change in Inventory
211.89211.8995.2656.1464.42-33.24
Change in Accounts Payable
-26.88-26.8830.382.29259.98-80.5
Change in Other Net Operating Assets
---1.350.561.36-
Operating Cash Flow
170.4258.3135.29-175.93105.53-223.32
Operating Cash Flow Growth
-3.88%90.93%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-24.82-53.48-54.02-84.54-83.34-6.93
Sale of Property, Plant & Equipment
0.210.20.530.03220.0921.63
Cash Acquisitions
-38.26-60.51-15.86-6.94-0.560
Divestitures
---0.992.40.16-
Investment in Securities
-2.12-2.05-0.571.76-209.3364.75
Other Investing Activities
5.12-7.144.53-9.875.58-
Investing Cash Flow
-59.85-122.96-64.89-102.24-93.6379.45

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
----139.5297.1
Long-Term Debt Issued
-338.07486.88629.11884.28568.05
Total Debt Issued
359.71338.07486.88629.111,024865.15
Short-Term Debt Repaid
-----189.5-272.3
Long-Term Debt Repaid
--416.38-492.61-438.57-798.36-807.14
Lease Payments
-19.41-19.41-20.15-35.22-28.6-41.59
Total Debt Repaid
-431.55-416.38-492.61-438.57-987.86-1,079
Net Debt Issued (Repaid)
-71.83-78.3-5.73190.5335.91-214.29
Issuance of Common Stock
---0.71-396.57
Common Dividends Paid
-34.22-50.06-43.31-43.81-56.32-50.08
Other Financing Activities
7.08-16.36-16.22-15.7873.7173.71
Financing Cash Flow
-98.97-144.72-65.26131.6653.3205.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.10.060.09---
Net Cash Flow
11.48-9.335.23-146.5165.262.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
145.58204.8281.27-260.4822.19-230.25
Free Cash Flow Growth
3.31%152.03%----
Free Cash Flow Margin
20.38%28.23%10.14%-38.85%2.35%-36.09%
Free Cash Flow Per Share
0.500.710.28-0.900.09-0.87
Levered Free Cash Flow
146.68186.55241.67-96.8381.23-304.4
Unlevered Free Cash Flow
152.5219.88264.5-77.7399.47-273.93
Free Cash Flow After Leases
126.17185.4161.11-295.69-6.41-271.84

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
18.5316.3214.1510.4428.7633.96
Change in Working Capital
248.86248.8670.8976.79-10.19-220.59